Nisa Investment Advisors
ATRA icon

Nisa Investment Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Nisa Investment Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$35 – 2939
2024
Q1 		$35 Sell
2
-1
-33% -$18 ﹤0.01% 2758
2023
Q4 		$41 Sell
3
-29
-91% -$676 ﹤0.01% 2634
2023
Q3 		$1.19K Buy
32
+3
+10% +$134 ﹤0.01% 2372
2023
Q2 		$1.16K Sell
29
-29
-50% -$1.64K ﹤0.01% 2418
2023
Q1 		$4K Sell
58
-116
-67% -$11.3K ﹤0.01% 2253
2022
Q4 		$14K Sell
174
-84
-33% -$8.75K ﹤0.01% 2129
2022
Q3 		$28K Buy
258
+232
+892% +$26.1K ﹤0.01% 1950
2022
Q2 		$5K Hold
26
– – ﹤0.01% 2266
2022
Q1 		$6K Buy
+26
New +$8.28K ﹤0.01% 2277
2021
Q4 		– Sell
-185
Closed -$83K – 2209
2021
Q3 		$83K Hold
185
– – ﹤0.01% 1780
2021
Q2 		$72K Hold
185
– – ﹤0.01% 1833
2021
Q1 		$66K Hold
185
– – ﹤0.01% 1921
2020
Q4 		$91K Buy
185
+158
+585% +$72.9K ﹤0.01% 1770
2020
Q3 		$9K Buy
27
+10
+59% +$3.4K ﹤0.01% 2128
2020
Q2 		$6K Hold
17
– – ﹤0.01% 1990
2020
Q1 		$4K Buy
17
+8
+89% +$2.54K ﹤0.01% 1967
2019
Q4 		$4K Hold
9
– – ﹤0.01% 1941
2019
Q3 		$3K Hold
9
– – ﹤0.01% 1950
2019
Q2 		$5K Hold
9
– – ﹤0.01% 1888
2019
Q1 		$9K Hold
9
– – ﹤0.01% 1774
2018
Q4 		$8K Hold
9
– – ﹤0.01% 1691
2018
Q3 		$10K Buy
+9
New +$8.8K ﹤0.01% 1719

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Centiva Capital
Centiva Capital New York $11.5B AUM 31.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Nisa Investment Advisors's ATRA Position: Q2 2024 in Review

Nisa Investment Advisors sold out of Atara Biotherapeutics (ATRA) in Q2 2024, closing a stake of 2 shares — an estimated $35 sold.

Nisa Investment Advisors first reported a position in ATRA in Q3 2018 and held it in 22 quarters. The position peaked at $91K in Q4 2020. 48 funds tracked by Wall St. Rank hold ATRA as of Q2 2024.

  • Nisa Investment Advisors reported no remaining Atara Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 2 Atara Biotherapeutics shares in Q2 2024, an estimated $35.
  • Nisa Investment Advisors first reported a position in Atara Biotherapeutics in Q3 2018 and held it in 22 quarters.
  • Nisa Investment Advisors's Atara Biotherapeutics position peaked at $91K in Q4 2020.
  • 48 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2024.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.